REN001 by Elleine Allapitan | Jul 5, 2023REN001 Summary: A double-blind, placebo-controlled, study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrial myopathy...
Recent Comments